BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6171817)

  • 1. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
    Hahne WF; Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that proglumide and benzotript antagonize secretagogue stimulation of isolated gastric parietal cells.
    Magous R; Bali JP
    Regul Pept; 1983 Nov; 7(3):233-41. PubMed ID: 6320314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
    Niederau C; Niederau M; Williams JA; Grendell JH
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proglumide analogues: potent cholecystokinin receptor antagonists.
    Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
    Iwamoto Y; Nakamura R; Akanuma Y
    Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists.
    Jensen RT; Jones SW; Gardner JD
    Biochim Biophys Acta; 1983 May; 757(2):250-8. PubMed ID: 6189522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic GMP does not inhibit protein kinase C-mediated enzyme secretion in rat pancreatic acini.
    Menozzi D; Sato S; Jensen RT; Gardner JD
    J Biol Chem; 1989 Jan; 264(2):995-9. PubMed ID: 2463255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do antagonists of pancreatic cholecystokinin receptors interact with central nervous system cholecystokinin receptors?
    Vigna SR; Szecòwka J; Williams JA
    Brain Res; 1985 Sep; 343(2):394-7. PubMed ID: 2996701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function studies of N-acyl derivatives of tryptophan that function as specific cholecystokinin receptor antagonists.
    Jensen RT; Jones SW; Gardner JD
    Biochim Biophys Acta; 1983 Dec; 761(3):269-77. PubMed ID: 6317050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
    Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells.
    Jensen RT; Lemp GF; Gardner JD
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2079-83. PubMed ID: 6246521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of proglumide on pancreatic acinar cell function.
    Williams JA; Bailey A; Steigerwalt RW
    Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence against cyclic GMP as a mediator of the actions of secretagogues on amylase release from guinea-pig pancreas.
    Gardner JD; Rottman AJ
    Biochim Biophys Acta; 1980 Feb; 627(3):230-43. PubMed ID: 6153277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues.
    Pandol SJ; Sutliff VE; Jones SW; Charlton CG; O'Donohue TL; Gardner JD; Jensen RT
    Am J Physiol; 1983 Nov; 245(5 Pt 1):G703-10. PubMed ID: 6195929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of cholera toxin on dispersed acini from guinea pig pancreas.
    Gardner JD; Rottman AJ
    Biochim Biophys Acta; 1979 Jun; 585(2):250-65. PubMed ID: 222350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analogue of substance P with broad receptor antagonist activity.
    Zhang L; Mantey S; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1988 Oct; 972(1):37-44. PubMed ID: 2460143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.